Claim validity of print advertisements found in otolaryngology journals

Archives of Otolaryngology - Head and Neck Surgery

Volumn 137, Issue 8, 2011, Pages 746-750

  Del Signore, Anthony ^a   Murr, Andrew H ^b   Lustig, Lawrence R ^b   Platt, Michael P ^c   Jalisi, Scharukh ^c   Pratt, Loring W ^a,b,c,d   Spiegel, Jeffrey H ^c  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BOSTON MEDICAL CENTER   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADVERTIZING; ARTICLE; CLAIM VALIDITY; CROSS-SECTIONAL STUDY; HUMAN; MEDICAL EDUCATION; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDICAL PRACTICE; OTORHINOLARYNGOLOGY; PHYSICIAN; PUBLICATION; VALIDITY;

ADVERTISING AS TOPIC; CROSS-SECTIONAL STUDIES; EVALUATION STUDIES AS TOPIC; EVIDENCE-BASED MEDICINE; OTOLARYNGOLOGY; PERIODICALS AS TOPIC;

EID: 84860424208     PISSN: 08864470     EISSN: 1538361X     Source Type: Journal    
DOI: 10.1001/archoto.2011.75     Document Type: Article

References (26)

1. Bhattacharyya T., Tornetta P. III, Healy W.L., Einhorn T.A. The validity of claims made in orthopaedic print advertisements. J Bone Joint Surg Am. 2003;85(7):1224-1228. (Pubitemid 36764929)
2. Gutknecht D.R. Evidence-based advertising? a survey of four major journals. J Am Board Fam Pract. 2001;14(3):197-200. (Pubitemid 33606226)
3. Vlassov V., Mansfield P., Lexchin J., Vlassova A. Do drug advertisements in Russian medical journals provide essential information for safe prescribing? West J Med. 2001;174(6):391-394. (Pubitemid 32661798)
4. Loke T.W., Koh F.C., Ward J.E. Pharmaceutical advertisement claims in Australian medical publications. Med J Aust. 2002;177(6):291-293.
5. Wilkes M.S., Doblin B.H., Shapiro M.F. Pharmaceutical advertisements in leading medical journals: Experts' assessments. Ann Intern Med. 1992;116(11):912-919. (Pubitemid 23034784)
6. Lexchin J., Holbrook A. Methodologic quality and relevance of references in pharmaceutical advertisements in a Canadian medical journal. CMAJ. 1994;151(1):47-54. (Pubitemid 24246394)
7. Lankinen K.S., Levola T., Marttinen K., Puumalainen I., Helin-Salmivaara A. Industry guidelines, laws and regulations ignored: Quality of drug advertising in medical journals. Pharmacoepidemiol Drug Saf. 2004;13(11):789-795. (Pubitemid 39496901)
8. Villanueva P., Peiró S., Librero J., Pereiró I. Accuracy of pharmaceutical advertisements in medical journals. Lancet. 2003;361(9351):27- 32. (Pubitemid 36050958)
9. Committee on Public Health, The New York Academy of Medicine. Report on pharmaceutical advertising. Bull N Y Acad Med. 1962;38:46-58.
10. Smith M.C. Drug product advertising and prescribing: A review of the evidence. Am J Hosp Pharm. 1977;34(11):1208-1224.
11. Weeks W.B., Wallace A.E., Kimberly B.C. The changing face of pharmaceutical advertising: A look at medical journals reveals a new era in advertising. Mark Health Serv. 2001;21(3):27-30. (Pubitemid 32777219)
12. Bramean A. Some questions and answers on prescription drug advertising. http://findarticles.com/p/articles/mi-m1370/is-4-38/ai-n6132447/. Accessed April6, 2011.
13. United States Government Accountability Office. Prescription drugs: FDA's oversight of the promotion of drugs for off-label uses. http://www.gao.gov/new. items/d08835.pdf. Accessed May 10, 2010.
14. United States Government Accountability Office. Prescription drugs: improvements needed in FDA's oversight of direct-to-consumer advertising. http://www.gao.gov/new.items/d0754.pdf. Accessed May 10, 2010.
15. Van Winkelen P., Van Denderen J.S., Vossen C.Y., Huizinga T.W., Dekker F.W. How evidence-based are advertisements in journals regarding the subspecialty of rheumatology? Rheumatology (Oxford). 2006;45(9):1154-1157. (Pubitemid 44542108)
16. Bartus C.L., Katz K.A. Advertising in dermatology journals: Journals' and journal editors' policies, practices, and attitudes. J Am Acad Dermatol. 2006;55(1):116-122. (Pubitemid 43867034)
17. Avorn J., Chen M., Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med. 1982;73(1):4-8. (Pubitemid 12048270)
18. Fassold R.W., Gowdey C.W. A survey of physicians' reactions to drug promotion. Can Med Assoc J. 1968;98(14):701-705.
19. Christensen D.B., Wertheimer A.I. Sources of information and influence on new drug prescribing among physicians in an HMO. Soc Sci Med. 1979;13A(3):313-322. (Pubitemid 9196990)
20. Linn L.S., Davis M.S. Physicians' orientation toward the legitimacy of drug use and their preferred source of new drug information. Soc Sci Med. 1972;6(2):199-203.
21. Kleinman L.C., Kosecoff J., Dubois R.W., Brook R.H. The medical appropriateness of tympanostomy tubes proposed for children younger than 16 years in the United States. JAMA. 1994;271(16):1250-1255. (Pubitemid 24121808)
22. International Federation of Pharmaceutical Manufacturers and Associations. IFPMA Code of Pharmaceutical Marketing practices: 2006 revision. http://www.ifpma.org/fileadmin/templates/EthicalPromotion/pdfs/ IFPMA-Code-2006-Revision-EN.pdf. Accessed May 10, 2010.
23. Gagnon M.A., Lexchin J. The cost of pushing pills: A new estimate of pharmaceutical promotion expenditures in the United States. PLoS Med. 2008;5(1):e1.
24. Mitka M. Improving drug safety. JAMA. 2010;304(10):1060.
25. Othman N., Vitry A., Roughead E.E. Quality of pharmaceutical advertisements in medical journals: A systematic review. PLoS One. 2009;4(7):e6350.
26. Cooper R.J., Schriger D.L. The availability of references and the sponsorship of original research cited in pharmaceutical advertisements. CMAJ. 2005;172(4):487-491. (Pubitemid 40278474)